phosphorodithioic acid has been researched along with Melanoma in 4 studies
*Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ager, CR; Curran, MA; Di Francesco, ME; Jones, P; Wei, Z; Zhang, H | 1 |
Amartey, J; Noe, CR; Stessl, M; Winkler, J | 1 |
Apfel, R; Bogdahn, U; Bosserhoff, AK; Fabel, K; Hau, P; Jachimczak, P; Schlingensiepen, KH; Schuler-Thurner, B; Tschertner, I; Wise, P | 1 |
Benimetskaya, L; Colombini, M; Lai, JC; Miller, P; Stein, CA; Tan, W | 1 |
4 other study(ies) available for phosphorodithioic acid and Melanoma
Article | Year |
---|---|
Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cytosol; Heterocyclic Compounds; Humans; Immunity, Innate; Immunotherapy; Interferon-beta; Melanoma; Melanoma, Experimental; Membrane Proteins; Mice; Nucleotides, Cyclic; Phosphates; Signal Transduction; Tumor Microenvironment | 2019 |
Off-target effects related to the phosphorothioate modification of nucleic acids.
Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Humans; Intercellular Adhesion Molecule-1; Lactates; Melanoma; Oligonucleotides, Antisense; Phosphates; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Thionucleotides | 2010 |
Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
Topics: Cell Line, Tumor; Cytotoxicity, Immunologic; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Glioma; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocytes, Mononuclear; Lymphocyte Activation; Melanoma; Neoplasm Proteins; Oligonucleotides, Antisense; Phosphates; Proteins; Recombinant Proteins; Thionucleotides | 2005 |
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.
Topics: Base Sequence; Cell Line, Tumor; Cytochromes c; Humans; Ion Channel Gating; Melanoma; Mitochondria; Mitochondrial Membranes; Oligonucleotides; Phosphates; Thionucleotides; Voltage-Dependent Anion Channels | 2006 |